Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
AMEX
Asterias Biotherapeutics Common Series A (AST)
Asterias Biotherapeutics Common Series A (AST) News

Asterias Biotherapeutics, Inc. (AST)

Asterias Biotherapeutics Common Series A

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AST

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
20/03/2019	21:07	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	AMEX:AST	Asterias Biotherapeutics Common Series A
20/03/2019	10:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
20/03/2019	10:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
20/03/2019	10:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:55	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:55	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:53	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:52	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:49	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
14/03/2019	18:48	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
12/03/2019	21:00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
12/03/2019	20:52	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
12/03/2019	10:06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
08/03/2019	21:07	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
08/03/2019	20:18	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	AMEX:AST	Asterias Biotherapeutics Common Series A
05/03/2019	21:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
05/03/2019	21:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
05/03/2019	21:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/03/2019	21:35	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/03/2019	21:34	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
28/02/2019	22:24	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
04/02/2019	22:26	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	AMEX:AST	Asterias Biotherapeutics Common Series A
24/01/2019	21:01	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
24/01/2019	12:00	GlobeNewswire Inc.	Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury	AMEX:AST	Asterias Biotherapeutics Common Series A
04/01/2019	22:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
04/01/2019	22:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
04/01/2019	13:00	GlobeNewswire Inc.	BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...	AMEX:AST	Asterias Biotherapeutics Common Series A
06/12/2018	11:22	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
06/12/2018	11:17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A

Showing the most relevant articles for your search:AMEX:AST

1 2 3 4 5 6 7 8 9 10 Next >>

Anglo Asian Mining

Petrel Resources

Alliance Pharma

Kefi Gold And Copper

Supply@me Capital

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions